Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical passes the values gate
Price143.21 USD
Fair value166.01
Ethical score78.5/100
RatingFAIR VALUE
Our investment reviews on this name
2026-07-24Read Markup140.96+1.6% to today ✓
2026-07-02Read Distribution130.93+9.4% to today
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
CBRE Group holds its Distribution at $143.21. The statistical read favours the sellers, held for 129 days.
As held on the ledger · 2026-09-21
Phase
Distribution · caution
Quantitative state
The statistical read favours the sellers, held for 129 days
Price at the screen
$143.21
Valuation
32.77 trailing · 15.75 forward price to earnings
Values screen
PASS· score 78.5
Beta
1.19
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
32.36%
Below 33%
Interest-bearing debt is just 32.4% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
2.82%
Below 33%
Cash held in interest-bearing accounts and securities is 2.8% of assets, under the one-third limit.
Pass
Receivables
32.87%
Below 49%
Money owed to the company is 32.9% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is Worth
The Fair Value Range
Our framework reads FAIR VALUE: it trades at roughly a 16% discount to our $166.01 fair value, weak competitive moat, 15.50% revenue growth.
Fair value range in USD, drawn from the 2026-09-21 screen. The gold marker is the market price at the same screen. A 15.9% margin of safety to the base estimate.
Third-party analyst targets: 12 covering, consensus Buy. The average target sits +30% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-21 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
The Broker Behind Every Major Office Deal
Picture a skyscraper going up in London or New York. CBRE is the firm sorting the leases, managing the build and moving the money. Revenue is rising 19 percent, return on equity sits at 16 percent and the shares trade with a 14 percent margin of safety below our fair value. That combination keeps it in play despite a weak moat.
The risks are straightforward. Profit margins run at just 3 percent and the real estate cycle can turn quickly, turning today’s steady fees into tomorrow’s shortfall. A low forward multiple of 15.9 times does not change the fact that peak earnings often look cheap right before volumes drop.
The ethical screen is clear and the business model is proven, yet nothing here screams durable advantage. Analysis, not advice.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
CBRE trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-24Markup$152.10+7.9%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (12 analysts) rates it buy, with a mean price target of $178.
2026-07-24Markup · changed$140.96+7.7%Entry 4
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (12 analysts) rates it buy, with a mean price target of $178.
2026-07-18Distribution$130.93+0.0%Entry 3
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 1%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (12 analysts) rates it buy, with a mean price target of $178.
2026-07-03Distribution$130.93+0.0%Entry 2
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns.
2026-07-02Distribution$130.93Entry 1
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.